Insights into podophyllotoxin lactone features: New cyclolignans as potential dual tubulin‐topoisomerase II inhibitors
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.202400600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Ángela-Patricia Hernández und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Química Farmacéutica, Departamento de Ciencias Farmacéuticas, Facultad de Farmacia, CIETUS/IBSAL, Campus Miguel de Unamuno, Universida…. Hauptthemen laut MEDLINE: Podophyllotoxin, Topoisomerase II Inhibitors, Lactones, Tubulin Modulators. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Junta de Castilla y León, Instituto de Salud Carlos III, CSIC's Global Health Platform.
Abstract (Originalsprache)
Chemomodulation of natural cyclolignans as podophyllotoxin has been a successful approach to obtain semisynthetic bioactive derivates. One example of this approach is the FDA‐approved drug etoposide for solid and hematological tumors. It differs from the antimitotic activity of the natural product in its mechanism of action, this drug being a topoisomerase II inhibitor instead of a tubulin antimitotic. Within the molecular requirements for the activity of these compounds, the trans‐γ‐lactone moiety presented in the parent compound has always been a feature to be explored to chemomodulate its bioactivity. In this study, we have obtained different compounds that comply with the molecular characteristics for antitubulin and antitopoisomerase II activity combined in a single molecule. Furthermore, we explored the influence of the trans ‐lactone moiety on the final activity, finding that the cis ‐lactone was also interesting in terms of bioactivity. The best values of cytotoxicity and cell cycle inhibition were obtained for a compound lacking the lactone ring, thus mimicking the podophyllic aldehyde functionalization, a selective antimitotic podophyllotoxin derivate. The analogs with cis ‐lactone also presented interesting cytotoxic activity. The present study illustrates the potential of the chemomodulation of natural products such as natural cyclolignan podophyllotoxin derivates for the discovery of new antitumor agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Química Farmacéutica, Departamento de Ciencias Farmacéuticas, Facultad de Farmacia, CIETUS/IBSAL, Campus Miguel de Unamuno, Universidad de Salamanca, Salamanca, Spain.
- Department of Medicine and General Cytometry Service-Nucleus, CIBERONC CB16/12/00400, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), IBSAL, Campus Miguel de Unamuno, Universidad de Salamanca-CSIC, Salamanca, Spain.
- Departamento de Química Física, Facultad de Ciencias Químicas, Universidad de Salamanca, Salamanca, Spain.
- Departamento de Química Orgánica, Facultad de Ciencias Químicas, Universidad de Salamanca, Salamanca, Spain.
- Proteomics Unit, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain.
ORCID-Profile: Carolina Miranda-Vera, Anzhela Veselinova, Pablo G Jambrina, Pablo A García, David Díez, María Ángeles Castro, Manuel Fuentes
Förderung
- Junta de Castilla y León
- Instituto de Salud Carlos III
- CSIC's Global Health Platform
- Spanish Ministry of Science and Innovation
- Junta de Castilla y León and European Social Fond
- European Social Fund
- University of Salamanca
- Universidad de Salamanca
Zitieren
APA
Hernández, Á. P., Rosales-Fernández, C., Miranda-Vera, C., Veselinova, A., Jambrina, P. G., García-García, P., García, P. A., Díez, D., Castro, M. Á., & Fuentes, M. (2025). Insights into podophyllotoxin lactone features: New cyclolignans as potential dual tubulin‐topoisomerase II inhibitors. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400600
Vancouver
Hernández ÁP, Rosales-Fernández C, Miranda-Vera C, Veselinova A, Jambrina PG, García-García P, et al. Insights into podophyllotoxin lactone features: New cyclolignans as potential dual tubulin‐topoisomerase II inhibitors. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400600
BibTeX
@article{Hernndez2025,
author = {Hernández, Ángela-Patricia and Rosales-Fernández, Celia and Miranda-Vera, Carolina and Veselinova, Anzhela and Jambrina, Pablo G and García-García, Pilar and García, Pablo A and Díez, David and Castro, María Ángeles and Fuentes, Manuel},
title = {Insights into podophyllotoxin lactone features: New cyclolignans as potential dual tubulin‐topoisomerase II inhibitors},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.202400600}
}
EUVIMED